Cao, X., Lu, Y., Zhang, J., Wei, Z., Liu, D., Xiong, M., Zhao, Y., Zhou, J., Sun, R., Niu, M., Pan, F., Long, J., Lu, P. (2025). Optimizing letermovir timing: Day +5 to +8 post haplo-HSCT minimizes EBV dnaemia without compromising CMV prophylaxis. Blood. https://doi.org/10.1182/blood-2025-2500